jump to content  sitemap
Division of Division of Pulmonary, Allergy, Critical Care & Sleep Medicine : Department of Internal Medicine : College of Medicine : The Ohio State University
http://internalmedicine.osu.edu/cardiovascular//pulmonary/7649.cfm

 
Mercury's Link to Heart Disease Begins in Blood Vessel Walls
:: About the Division ::
Welcome from the Director
Alumni Information
Best Doctors in America®
Faculty Opportunities
Faculty in the News
2008
2007
2006
2005
2004
History of the Division

Home > About the Division > Faculty in the News > 2007 > Mercury's Link to Heart Disease Begins in Blood Vessel Walls

Mercury's Link to Heart Disease Begins in Blood Vessel Walls
06/2007

Heavy metals and other toxins have been linked to many human diseases, but determining exactly how they damage the body remains a mystery in many cases.

However, new research focusing on a relatively obscure, misunderstood protein suggests mercury’s link to heart disease can be traced to activation of this enzyme, which triggers a process leading to plaque buildup in blood vessel walls.

The study, conducted by researchers at OSU Medical Center, examined three forms of mercury, matching their characteristics in the environment. Each form caused changes in the behavior of cells that line the blood vessel walls and that can lead to cardiovascular diseases.

The study also suggests that chelation therapy, a process that removes metals from the body, and antioxidants both show signs of suppressing this activity and might be key to reducing the damage caused by mercury, and possibly other heavy metals.

The research was published in a recent issue of the International Journal of Toxicology.

“Mercury has been implicated as a risk factor in cardiovascular disease because of environmental concerns both from contamination and the atmosphere. But no one has looked at heavy metal regulation of this enzyme,” says Narasimham Parinandi, PhD, director of the Lipidomics and Lipid Signaling Laboratory at Ohio State's Medical Center, and senior author of the study.

“If we understand this regulation and know how to block it, we can come up with proper ways to prevent the activity.”

Parinandi and colleagues focused on activation of an enzyme called phospholipase D, or PLD, in cells that line arteries in the lung. They exposed the cells to the inorganic, environmental and pharmaceutical forms of mercury, and observed that all three forms activated the enzyme.

This activation involves a complex sequence of events in the cell membranes that in turn releases phosphatidic acid, which can damage cells in the vessel lining – called endothelial cells – and is believed to contribute to vascular disorders.

This item was the result of a news release distributed by OSU Medical Center Research News, available online at: http://www.medctr.ohio-state.edu/DetailNews.aspx?NewsId=01d4bd38-7bd2-46a7-b86c-08a96c4b4208&CategoryId=2


Department of Internal Medicine http://www.internalmedicine.osu.edu
US News and World Report Best Hospitals 2007

The Ohio State University | College of Medicine
Department of Internal Medicine
Division of Pulmonary, Allergy, Critical Care & Sleep Medicine
201 DHLRI | 473 W. 12th Avenue | Columbus, OH 43210
Ph: 614.293.4925 | Contact Us